Press releases
Read more:
Categories
2020
2020-09-30 08:12
Nanologica’s patent granted in Europe
The European Patent Office has granted Nanologica’s patent titled ”A process for manufacturing porous silica particles loaded with at least...
2020-06-26 09:36
Nanologica Signs Agreement with Vicore Pharma Worth up to MSEK 8
Nanologica AB has within the project with Vicore Pharma been assigned to commence preparative work for the manufacturing of GMP classified material. The...
2020-06-25 14:34
Nanologica Engages Per Möller as Scientific Advisor within Preparative Chromatography
Nanologica AB has engaged Per Möller, a distinguished scientist with industrial experience, for the purpose of having a qualified advisor for strategic...
2020-03-03 13:15
Nanologica Signs Distributor Agreement for the American, Canadian and European Market
Nanologica AB has signed a distribution agreement with American International Chemical LLC (AIC) for the American, Canadian and European market to further...
2019
2019-12-09 15:20
Renewed agreement with crop protection company
Nanologica has renewed the agreement with the crop protection company that during the year has performed field studies based on Nanologica’s formulation...
On Dec 5-6, Nanologica will take part in the inaugural Respiratory Drug Delivery conference in London, UK. The purpose of the conference is to bring together...
2019-11-14 08:22
Nanologica acknowledges World Diabetes Day
Diabetes is a disease affecting more than 400 million people worldwide, a number that is expected to increase to more than 640 million by 2040. In 2015...
Nanologica’s drug delivery platform NLAB Silica™ consists of nanoporous amorphous proprietary silica particles. By loading the API in NLAB...
2019-10-24 09:53
Nouryon Nordic prize winner Dr Sabrina Valetti
Dr Valetti conducted her research on mesoporous silica particles at Nanologica AB during 2014-2016, as recipient of the prestigious Marie Curie Post Doc...
2019-10-17 07:51
Nanologica’s collaboration project prolonged
The agreement between Nanologica and AstraZeneca for the evaluation of Nanologica’s pending patented technology applied to AstraZeneca materials...